Keytruda Approved for Leading Form of Lung Cancer
Keytruda (pembrolizumab) has been approved by the U.S. Food and Drug Administration to treat advanced cases of the most common ...
Keytruda (pembrolizumab) has been approved by the U.S. Food and Drug Administration to treat advanced cases of the most common ...
AbbVie (NYSE: ABBV), in cooperation with Neurocrine Biosciences, Inc. (NASDAQ: NBIX), today announced the completion of a Phase 2b clinical ...
Operational management in three divisions: Pharmaceuticals, Consumer Health and Crop Science / Dieter Weinand, Erica Mann and Liam Condon appointed ...
Ireland-based Perrigo has completed the acquisition of Belgium's over-the-counter (OTC) drugmaker Omega Pharma for around €3.8bn ($4.5bn). As part ...
Irish biopharmaceutical firm Horizon Pharma has signed an agreement to acquire US-based Hyperion Therapeutics for around $1.1bn. As part ...
30 March 2015 The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended Boehringer ...
GlaxoSmithKline (GSK) has entered an agreement with the UK's Department of Health to provide meningitis B vaccine for babies in ...
Merck KGaA is the latest company to join Big Pharma's recent round of executive musical chairs. The German drugmaker is ...
Good news for GlaxoSmithKline ($GSK): An FDA panel of experts says the efficacy and safety data for blockbuster wannabeBreo support ...
GSK today announced it will be a key partner, with an investment of $25m (approx £17m), in a pioneering new ...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.
